Analyst Downgrade Signal: AMLX from Outperform to In-line by Evercore ISI
Price Target: $--
Report Date: 03-08-2024
Symbol: AMLX - Amylyx Pharmaceuticals, Inc. Common Stock
Sector:
Industry: Biotechnology
Analyst Downgrade Signal: AMLX from Outperform to In-line by Evercore ISI
Price Target: $--
Amylyx Pharmaceuticals, Inc. Common Stock (AMLX)
, 02141
Phone:
Website: https://amylyx.com
CEO: None
ETF, BATS Exchange
Amylyx Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases in the United States and Canada. The company is developing AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and tauroursodeoxycholic acid for the treatment of ALS and other neurodegenerative diseases. It is also developing products for Wolfram syndrome and Alzheimer's diseases. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.
best trading signals, stock market trading signals, stock trading signals services, daily stock signals
Good stock signals have been found on this server. That is all we know.
+1 (407) 559-7228